Study of roluperidone for negative symptoms of schizophrenia
Treatments studied
Part of Mental health clinical trials.
This trial tests a new medicine called roluperidone for people with schizophrenia who have ongoing negative symptoms (like low motivation or social withdrawal) but stable positive symptoms (like hallucinations). It aims to see if the drug helps with these symptoms and if it can reduce the chance of relapse compared to other medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 55 years old and have a BMI of 35 or less.
- You need a diagnosis of schizophrenia for at least 1 year with stable symptoms (not getting worse) and living outside the hospital for the last 6 months.
- You cannot have other mental health conditions like major depression, bipolar disorder, or substance abuse.
- You must have a caregiver or family member who can help support you and provide information during the trial.
- You cannot be taking certain medications (like clozapine) and must be willing to stop your current psychiatric medicines for a short time.
- You must not have a history of suicidal behavior or serious medical conditions (heart, liver, kidney problems, etc.).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if berberine, a natural supplement, can help reduce negative symptoms like lack of motivation or social withdrawal in people with schizophrenia. It may work by affecting the brain and body.
This trial tests a new medicine, NBI-1117568, to see if it can help prevent a relapse of schizophrenia symptoms. It is for adults who have been stable on other antipsychotics and want to avoid returning to the hospital for a psychiatric stay.
This trial tests two medicines, deferiprone and N-acetylcysteine, taken together to see if they improve negative symptoms of schizophrenia, such as lack of motivation or pleasure. It aims to find a new option for people who still have these symptoms despite their current antipsychotic treatment.
This trial tests a new medication called SEP-363856 over a long period for people with schizophrenia who are currently stable. It looks at how well the drug works and its safety over time.
This trial tests a new combination pill (xanomeline/trospium) for people who started treatment for schizophrenia in the last 5 years, to see if it helps better than their current medicine. You would stop your current antipsychotic and switch to this study drug under close doctor supervision.
This trial tests an investigational medicine called NBI-1117568 in adults with schizophrenia who are currently having a relapse or worsening of symptoms and need to stay in the hospital. The goal is to see if the medicine is safe and effective.
Hear when a new Negative Symptoms of Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.